Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.45
19.01.23
-
19.01.24
-39.83%
24.04.23

Probably not worthwhile Investment
buy
Hutchison China MediTech Ltd ADR

Start price
Target price
Perf. (%)
€15.50
19.01.23
-
19.01.24
-21.29%
20.01.24

buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.16
18.01.23
-
18.01.24
-34.95%
21.01.23

Risky Investment
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€3.24
17.01.23
€5.00
31.12.25
-41.09%
05.05.23

Could be very worthwhile Investment >20% year
buy
Coloplast A/S B

Start price
Target price
Perf. (%)
€115.40
16.01.23
€150.00
16.01.24
-0.26%
02.02.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Future proof or reliable business model
buy
Vaxart Inc.

Start price
Target price
Perf. (%)
€1.07
14.01.23
-
14.01.24
-52.68%
15.01.24

Could be worthwhile Investment >10% per year
buy
First Wave BioPharma Inc.

Start price
Target price
Perf. (%)
€5.11
14.01.23
€14.00
28.02.25
-12.33%
05.05.23

Could be very worthwhile Investment >20% year
buy
Amicus Therapeutics Inc.

Start price
Target price
Perf. (%)
€11.78
13.01.23
€17.00
31.05.24
-9.18%
05.05.23

Could be very worthwhile Investment >20% year
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€5.52
13.01.23
-
13.01.24
9.62%
21.01.23

Risky Investment
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€18.50
12.01.23
€40.00
12.01.24
-11.14%
23.01.23

Could be very worthwhile Investment >20% year
buy
Novo Nordisk A/S

Start price
Target price
Perf. (%)
€123.16
12.01.23
-
12.01.24
53.06%
13.01.24

buy
Merck KGaA

Start price
Target price
Perf. (%)
€202.00
12.01.23
-
12.01.24
-27.75%
13.01.24

Novavax Inc.

Start price
Target price
Perf. (%)
€11.01
11.01.23
€6.00
11.01.24
-61.64%
12.01.24

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
buy
Enanta Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€46.60
11.01.23
€60.00
31.12.25
-30.47%
05.05.23

Could be very worthwhile Investment >20% year
buy
Hepion Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€12.12
10.01.23
€30.00
31.03.25
-7.13%
05.05.23

Could be very worthwhile Investment >20% year
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€325.15
10.01.23
-
10.01.24
77.15%
11.01.24

buy
Ocuphire Pharma Inc.

Start price
Target price
Perf. (%)
€3.20
10.01.23
€6.00
31.12.25
-28.13%
26.01.23

Could be very worthwhile Investment >20% year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€2.16
10.01.23
€4.00
31.12.25
-46.57%
05.05.23

Could be very worthwhile Investment >20% year
buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€3.98
09.01.23
€8.00
31.12.25
178.89%
05.05.23

Could be very worthwhile Investment >20% year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.05
09.01.23
-
20.04.26
161.40%
28.04.23

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€43.10
09.01.23
-
09.01.24
-0.35%
21.01.23

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€38.00
09.01.23
-
09.01.24
-1.05%
21.01.23

Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€3.95
08.01.23
-
08.01.24
271.87%
09.01.24

Risky Investment
buy
Lysogene SA

Start price
Target price
Perf. (%)
€0.21
07.01.23
-
07.01.24
-
08.01.24

Could be worthwhile Investment >10% per year
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.65
05.01.23
€25.00
05.02.23
23.66%
06.02.23

Could be very worthwhile Investment >20% year